International Clinical Trial: Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121985) titled 'Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy' on Aug. 6.

Study Type: Observational

Primary Sponsor: University of Erlangen-Nurnberg Medical School

Condition: CIDP - Chronic Inflammatory Demyelinating Polyneuropathy Guillain-Barre Syndrome (GBS)

Recruitment Status: Not recruiting

Date of First Enrollment: August 6, 2025

Target Sample Size: 30

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07121985

Published by HT Digital Content Services with permission from Hea...